Taleen G Hanania

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 53(Granted Patents)

Company Filing History:

14 out of 130

Sunovion Pharmaceuticals Inc.

patents

14 out of 16

Pgi Drug Discovery LLC

Sumitomo Pharma America, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11958862 - Compounds and compositions and uses thereof (2024-04-16),

2. 11332462 - Heteroaryl compounds and methods of use thereof (2022-05-17),

3. 11192885 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2021-12-07),

4. 11077090 - Compounds and compositions and uses thereof (2021-08-03),

5. 10927124 - Compounds and compositions and uses thereof (2021-02-23),

6. 10894033 - Multicyclic compounds and methods of use thereof (2021-01-19),

7. 10556890 - Heteroaryl compounds and methods of use thereof (2020-02-11),

8. 10336732 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2019-07-02),

9. 10196403 - Compounds and compositions and uses thereof (2019-02-05),

10. 10189825 - Heteroaryl compounds and methods of use thereof (2019-01-29),

11. 10085968 - Multicyclic compounds and methods of use thereof (2018-10-02),

12. 9856238 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2018-01-02),

13. 9758529 - Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders (2017-09-12),

14. 9351954 - Multicyclic compounds and methods of use thereof (2016-05-31),

15. 8710245 - Multicyclic compounds and methods of use thereof (2014-04-29),

Title: The Innovative Mind of Taleen G. Hanania: A Focus on Neurological Treatments

Introduction: Taleen G. Hanania, a prominent inventor based in Valhalla, NY, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 15 patents. Her work predominantly focuses on developing compounds and compositions aimed at treating various neurological and psychiatric conditions.

Latest Patents: Among her latest innovations, Taleen has filed patents for compounds that showcase her commitment to addressing serious health issues. One of her notable patents involves compounds of a specific formula for pharmaceutical compositions and methods for treating neurological or psychiatric diseases and disorders. This innovative research offers potential breakthroughs in treatment methods for individuals in need. Additionally, her patent concerning heteroaryl compounds addresses methods of synthesis and their application in treating various neurological disorders, including psychosis and schizophrenia.

Career Highlights: Throughout her career, Taleen has worked with prominent pharmaceutical companies, including Sunovion Pharmaceuticals Inc. and Pgi Drug Discovery LLC. Her contributions have been instrumental in developing therapeutic solutions that cater to the pressing needs of patients suffering from complex neurological ailments.

Collaborations: Collaboration has played a key role in Taleen’s success as an inventor. She has worked alongside esteemed colleagues such as Liming Shao and John Emmerson Campbell, contributing to a synergy of ideas and expertise that has propelled her research forward.

Conclusion: Taleen G. Hanania stands as an inspiring figure in the realm of innovation, particularly in the field of pharmaceuticals focused on neurological treatments. With her extensive patent portfolio and collaborative efforts, she continues to pave the way for advancements that can significantly change the trajectory of patient care in mental health. Her dedication to developing effective treatments reinforces the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.